Medical Device Trials: Patient Recruitment Differences?
Praxis' director of marketing, Chris Layfield, offers insight into patient recruitment and developing a strategic recruitment plan when conducting medical device trials.
Medical Device Trials: Patient Recruitment Differences?
Chris Layfield, director of marketing at Brentwood, TN-based Praxis, told Applied Clinical Trials, “Like any trial, pharmaceutical or device, the process to developing a strategic recruitment plan is the same. One must fully understand the protocol and devise procedures to the extent that an accurate patient profile can be established. Without this, one cannot hope to effectively create a targeted reach program.”
Layfield explained after that is established, the appropriate primary, secondary and experiential research is done to determine how best to reach the persons identified in the profile – those that will be the most likely candidates for trial participation. Layfield offered this example; an acute situation where a new implantable device is being tested in heart attack patients. “If the decision to try the new device were to be needed within several hours or even less after a heart procedure then, information needs to be available to the treating physician and the family of the candidate at the time they present at the ER.”
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
